← FDA Drug Approvals (Drugs@FDA)

AGENERASE

NDA · New Drug Application · Sponsor: GLAXOSMITHKLINE · Approved 1999-04-15

Drug application

FDA Application #

NDA021039

Application type

New Drug Application

Brand name

AGENERASE

Generic name

Amprenavir

Active ingredients

AMPRENAVIR

Dosage form

SOLUTION

Route

ORAL

Marketing status

Discontinued

Sponsor

GLAXOSMITHKLINE

First approval

1999-04-15

Source

Authoritative

Drugs@FDA application overview

Machine

JSON-LD · Markdown